Search Results - "Svensson, K.A."

P.3.b.003 Characterization of [3 H]-LY508869 – a novel selective metabotropic glutamate 2 positive allosteric potentiator ligand by Falcone, J.F, Schkeryantz, J.M, Heinz, B, Wang, X, Catlow, J.T, Svensson, K.A

Get full text

Common discriminative stimulus properties in rats of muscarinic antagonists, clozapine and the D 3 preferring antagonist PNU-99194A: an analysis of possible mechanisms by Goudie, A.J, Baker, L.E, Smith, J.A, Prus, A.J, Svensson, K.A, Cortes-Burgos, L.A, Wong, E.H.F, Haadsma-Svensson, S

“…Dopamine D 3 receptors have been implicated in the aetiology of schizophrenia and the actions of antipsychotic drugs. The initial studies reported here…”
Get full text

Central opioid and mesolimbic dopamine neurotransmission forms a nexus of neural pathways supporting motivation, palatability, drug addiction and obesity by Statnick, M.A., Mitch, C.H., Sindelar, D.K., Coskun, T., Pintar, J.E., Gehlert, D.R., Phebus, L.A., Svensson, K.A., Shannon, H.E., McKinzie, D.L., Eastwood, J., Emmerson, J., Heiman, M.L.

Get full text

PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson’s Disease by Nichols, N.F, Cimini, M.G, Haas, J.V, Staton, B.A, Tedroff, J, Svensson, K.A

“…PNU-96391A is a weak dopamine (DA) D 2 receptor antagonist with behavioral stabilizing properties. Previous experiments revealed that PNU-96391A antagonizes…”
Get full text

Recent developments in metabotropic glutamate receptors as novel drug targets by O´Neil, M.J., Fell, M.J., Svensson, K.A., Witkin, J.M., Mitchell, S.N.

Get full text